{"organizations": [], "uuid": "a217bdc92cdaf4c9d04ce95660a1c21b8d38501b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-neovacs-raises-1-million-euros-in/brief-neovacs-raises-1-million-euros-in-private-placement-and-3-8-million-euros-by-issue-of-convertible-bonds-idUSFWN1QI1H0", "country": "US", "domain_rank": 408, "title": "BRIEF-Neovacs Raises 1 Million Euros In Private Placement And 3.8 Million Euros By Issue Of Convertible Bonds‍​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.028, "site_type": "news", "published": "2018-03-01T01:12:00.000+02:00", "replies_count": 0, "uuid": "a217bdc92cdaf4c9d04ce95660a1c21b8d38501b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-neovacs-raises-1-million-euros-in/brief-neovacs-raises-1-million-euros-in-private-placement-and-3-8-million-euros-by-issue-of-convertible-bonds-idUSFWN1QI1H0", "ord_in_thread": 0, "title": "BRIEF-Neovacs Raises 1 Million Euros In Private Placement And 3.8 Million Euros By Issue Of Convertible Bonds‍​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - NEOVACS SA:\n* RAISES EUR 1 MILLION IN PRIVATE PLACEMENT AND EUR 3.8 MILLION IN CONVERTIBLE BONDS ISSUE‍​\n* CONVERTIBLE BONDS’ MATURITY DATE FEB 26, 2020‍​\n* BONDS SUBSCRIBED BY 3 EUROPEAN INVESTORS, PRIVATE PLACEMENT SUBSCRIBED BY 2 FRENCH INSTITUTIONAL INVESTORS\n* PHASE IIB CLINICAL TRIAL OF IFNA KINOIDE LUPUS TREATMENT EXPECTED IN JUNE 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-01T01:12:00.000+02:00", "crawled": "2018-03-01T21:10:53.041+02:00", "highlightTitle": ""}